Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Rating of “Hold” from Brokerages

Simulations Plus, Inc. (NASDAQ:SLP) has been given an average rating of “Hold” by the eleven research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, five have given a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $24.40.

A number of equities analysts recently weighed in on the stock. Citigroup restated a “market perform” rating on shares of Simulations Plus in a report on Tuesday, October 28th. Zacks Research raised Simulations Plus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 28th. Weiss Ratings restated a “sell (d-)” rating on shares of Simulations Plus in a research note on Wednesday, October 8th. TD Cowen assumed coverage on Simulations Plus in a report on Tuesday, September 30th. They set a “hold” rating and a $16.00 price target on the stock. Finally, Cowen assumed coverage on Simulations Plus in a research report on Tuesday, September 30th. They set a “hold” rating on the stock.

Simulations Plus Stock Performance

NASDAQ:SLP opened at $17.29 on Friday. The firm has a 50-day simple moving average of $16.45 and a two-hundred day simple moving average of $18.01. The firm has a market cap of $348.00 million, a P/E ratio of -5.49 and a beta of 0.98. Simulations Plus has a fifty-two week low of $12.39 and a fifty-two week high of $37.67.

Institutional Trading of Simulations Plus

A number of large investors have recently made changes to their positions in the stock. Raymond James Financial Inc. bought a new position in Simulations Plus during the second quarter valued at approximately $25,000. Quarry LP bought a new stake in Simulations Plus in the 3rd quarter worth approximately $28,000. CWM LLC raised its stake in Simulations Plus by 3,729.1% during the 3rd quarter. CWM LLC now owns 2,106 shares of the technology company’s stock valued at $32,000 after buying an additional 2,051 shares during the last quarter. Farther Finance Advisors LLC bought a new position in shares of Simulations Plus during the 3rd quarter valued at $40,000. Finally, AlphaQuest LLC purchased a new position in shares of Simulations Plus in the 2nd quarter worth $69,000. 78.08% of the stock is currently owned by institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.